Ceftolozane/Tazobactam (MK-7625A) Plus Metronidazole Versus Meropenem for Participants With Complicated Intra-abdominal Infection (MK-7625A-015)

NCT03830333 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

268

Enrollment

INDUSTRY

Sponsor class

Conditions

Complicated Intra-abdominal Infections

Interventions

DRUG: Ceftolozane/Tazobactam
DRUG: Metronidazole
DRUG: Meropenem
DRUG: Placebo

Sponsor

Merck Sharp & Dohme LLC